Skip to main content
EMVISION MEDICAL DEVICES LTD logo

EMVISION MEDICAL DEVICES LTD — Investor Relations & Filings

Ticker · EMV ISIN · AU0000028375 ASX Manufacturing
Open in API
Filings indexed 304 across all filing types
Latest filing 2020-12-16 Board/Management Inform…
Country AU Australia
Listing ASX EMV

About EMVISION MEDICAL DEVICES LTD

https://emvision.com.au/

EMVision Medical Devices Ltd is a medical technology company focused on the development and commercialization of portable medical imaging devices. The company specializes in electromagnetic microwave imaging technology designed for the rapid diagnosis and monitoring of stroke and traumatic brain injury. Its primary product is a portable brain scanner intended for use at the point of care, including intensive care units, emergency departments, and ambulances. By utilizing non-ionizing radiation, the technology provides a safe, cost-effective, and mobile alternative to traditional neuroimaging modalities like CT and MRI. The device aims to facilitate earlier clinical intervention by enabling bedside assessment, potentially improving patient outcomes through faster detection of ischemic and hemorrhagic strokes.

Recent filings

Filing Released Lang Actions
Prof Stuart Crozier Appointed as Chief Scientific Officer 2 pages 176.2KB
Board/Management Information Classification · 95% confidence The document is a company announcement about the appointment of a new Chief Scientific Officer, Professor Stuart Crozier, at EMVision Medical Devices Ltd. It details his background, role, and significance to the company. There is no financial data, no mention of financial results, no regulatory filings, no voting results, no capital changes, no legal proceedings, and no report attachments. The content focuses on management changes at the senior executive level. Therefore, the document fits the category of Board/Management Information (MANG). The document length is 7,627 characters, which is sufficient for a detailed announcement but does not contain financial statements or report data. Hence, the classification is MANG with high confidence.
2020-12-16 English
Change of Director's Interest Notice - Correction 4 pages 318.4KB
Director's Dealing Classification · 100% confidence The document is titled 'CORRECTION TO APPENDIX 3Y' and contains detailed information about changes in a director's interest in securities, including shareholdings and options. Appendix 3Y is a known regulatory form used in Australian markets to disclose changes in directors' interests. The content includes specifics about the director, the nature of the securities, dates, and the nature of the change. There is no financial performance data, earnings information, or management discussion. The document is a regulatory announcement about insider share transactions by a company director. Therefore, it fits the category of Director's Dealing (DIRS). The document length and detail support this classification with high confidence.
2020-12-13 English
Appendix 2A - Release of Restricted Securities 15 pages 301.6KB
Regulatory Filings Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes detailed information about the entity, the type of securities to be quoted, and the escrow period expiration. This form is a regulatory announcement related to securities quotation and not a financial report, earnings release, or management discussion. It is a formal regulatory filing required by the exchange to notify about securities quotation. Therefore, it fits best under the category of Regulatory Filings (RNS). The document length is substantial and contains detailed regulatory information, not just a brief announcement or a report publication notice.
2020-12-13 English
Appendix 2A - Exercise of Options 15 pages 302.4KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes detailed information about the entity, the type of securities being quoted, and the circumstances of the issue. This type of document is a regulatory announcement related to capital markets and securities issuance, specifically an application for quotation of new securities. It is not a financial report, earnings release, management discussion, or any other report type. It is a formal regulatory filing announcing the quotation of securities, which fits best under the category of Capital/Financing Update (CAP). The document is substantive and not a mere announcement of a report, so it is not RPA or RNS. Therefore, the classification is CAP with high confidence.
2020-12-13 English
EMVision Receives $1.28M R&D Tax Incentive Rebate for FY20 2 pages 193.9KB
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 14/12/20 from EMVision Medical Devices Ltd regarding the receipt of a $1.28 million R&D tax incentive rebate for the financial year ending 30 June 2020. It provides details about the rebate, the company's cash reserves, and background information about the company and its management. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is relatively short (5638 characters) and serves as a news release or update rather than a full financial report or regulatory filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Audit Report. It is an announcement of a financial event (receipt of a tax rebate) but not a capital or financing update in the sense of fundraising or capital structure changes. It is not a regulatory filing or certification. Given the nature of the content, it best fits under Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2020-12-13 English
Release of Restricted Securities from Escrow 1 page
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the release of restricted securities from escrow, including details about the number and class of shares and options being released. It references ASX listing rules and the IPO prospectus but does not contain financial statements or detailed financial analysis. The document length is only 2538 characters, which is quite short and typical for a regulatory announcement. It is not a full financial report, earnings release, or management discussion. The content fits the category of a Regulatory Filing (RNS) as it is a compliance announcement related to securities restrictions and their release, without constituting a full report or financial disclosure.
2020-12-06 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.